Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.

Millennium Cancer Center provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2004, the hospital is located in Gurgaon, India, and operates 100 beds, equipped with modern healthcare infrastructure.
CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.
Delhi, India
Max Super Speciality Hospital, Patparganj provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2005, the NABH, NABL, AACI hospital is located in Delhi, India, and operates 400 beds, equipped with modern healthcare infrastructure.
CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.
Srikara Hospitals, Miyapur is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2013, the NABH hospital is situated in Hyderabad, India and has 200 beds.
CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.
At Tx Hospitals Banjara Hills, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2020, this JCI, NABH hospital in Hyderabad, India has 100 beds and provides comprehensive cardiovascular care.
CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.
Choosing Manipal Hospital, Hebbal for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 1991, the NABL, NABH hospital in Bangalore, India has 280 beds and provides specialised cardiac services.
CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.
Max Super Speciality Hospital, Saket offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2006, the JCI, NABH hospital is located in Delhi, India and has 539 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.
Gurgaon, India
Fortis Memorial Research Institute provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2013, the JCI, NABH, NABL hospital is located in Gurgaon, India, and operates 311 beds, equipped with modern healthcare infrastructure.
CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.
Choosing Asian Institute of Medical Sciences for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 2010, the NABL, NABH hospital in Faridabad, India has 425 beds and provides specialised cardiac services.
CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.
At Apollo Hospital International Limited, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2003, this NABH, JCI hospital in Ahmedabad, India has 300 beds and provides comprehensive cardiovascular care.
CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.
Manipal Hospital, Gurugram provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2008, the NABL, NABH hospital is located in Gurgaon, India, and operates 380 beds, equipped with modern healthcare infrastructure.
CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.
At Manipal Hospitals Goa, Dona Paula, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 1994, this NABH hospital in Panjim, India has 235 beds and provides comprehensive cardiovascular care.
CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.
Fortis Hospital offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2006, the JCI, NABH hospital is located in Mohali, India and has 276 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.
Metro Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 1997, the NABL, NABH, ISO hospital is located in Noida, India, and operates 289 beds, equipped with modern healthcare infrastructure.
CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.
At Sharda Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2005, this NABH hospital in Noida, India has 1200 beds and provides comprehensive cardiovascular care.
CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.
Delhi, India
Fortis Flt. Lt. Rajan Dhall Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2006, the NABH hospital is located in Delhi, India, and operates 162 beds, equipped with modern healthcare infrastructure.
CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

Mr. Hailu Kassa underwent Coronary Artery Bypass Surgery in Vejthani Hospital, Thailand under the supervision of Dr. Piya, Cardio-Thoracic Surgeon

Patient Testimonial: Rod Schaubroeck from United States (U.S.A) underwent heart valve replacement at Fortis Hospital, India